"MORE THAN DOZEN" GENERIC FIRMS IMPLICATED IN FRAUD INVESTIGATIONS, REP. DINGELL SAYS; ANDA DISCREPANCIES CONTINUE DESPITE AUDITS AT PAR AND ATI

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".